MedTrace Logo

Definition and Management of Right Ventricular Injury in Adult Patients Receiving Extracorporeal Membrane Oxygenation

NCT05948332 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2024-04-16

No results posted yet for this study

Summary

The aim of this study is to identify existing definitions and therapeutic approaches for acute right ventricular injury (RVI) in patients receiving extracorporeal membrane oxygenation (ECMO) for respiratory support. The objective of the study is to generate expert consensus statements on the definition and management of acute RVI in this high-risk patient population, using a Delphi method. The standardised RVI definition during ECMO for respiratory support and a consensus-based management approach to RVI will facilitate systematic aggregation of data across clinical trials to harmonise patient selection and compare therapeutic interventions.

Conditions

  • Extracorporeal Circulation; Complications
  • Extracorporeal Membrane Oxygenation Complication
  • Right Heart Failure
  • Right Ventricular Dysfunction
  • Respiratory Failure
  • Respiratory Distress Syndrome

Interventions

BEHAVIORAL

Delphi Rounds to generate consensus opinions among Experts

The Investigators (Steering Committee) will select the experts from across the globe based on pre-specified qualification criteria and will conduct iterative Delphi rounds to generate consensus on the definition and management of acute RVI in patients with receiving V-V ECMO, among the Experts. The selection criteria will be self-assessed through a survey among the potential Experts.

Sponsors & Collaborators

  • Prashant Nasa

    lead OTHER

Principal Investigators

  • Vasileios Zochios, MRCP FFICM · University Hospitals of Leicester NHS Trust, Glenfied Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2023-11-26
Completion
2024-01-01

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05948332 on ClinicalTrials.gov